 |
|||||||||||
   |
Coverage of 2007 ICAAC
|
||||||||||
| Recent study shows exceptional potency of new integrase inhibitor |
|
| Options continue to increase for first line therapy |
|
| Prezista performs better than Kaletra for first line therapy |
|
Early study results of etravirine showing promise |
IN THE NEWS
ARCHIVES
CONFERENCE
COVERAGE
2007 ICAAC
PROJECT INFORM
CITED IN MEDIA
© 2008 Project Inform 1375 Mission
Street, San Francisco, CA 94103 415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST